shutterstock_olivier_le_moal_756213100

Olivier Le Moal / Shutterstock.com

19 March 2020AmericasRory O'Neill

PacBio pledges to fight invalidation of patents after bitter dispute

California-based Pacific Biosciences (PacBio) has accused a UK rival of exploiting the coronavirus pandemic in a patent infringement trial.

Already registered?

Login to your account

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

More features

To disclose or not: Pharma patents face new AI reality

Trade secrets go global: How brand owners face a high-stakes battlefront

Killing the golden goose of US drug innovation (Part II): Drug pricing myths

Former pharma GC brings in-house perspective to McGuireWoods

Sandoz eyes US biosimilar launch as Regeneron settles

Killing the golden goose of US drug innovation (Part I): Follow the money

Buchalter brings in new partner to head up medtech

Trump’s march-in rights threat: Why pharma is rethinking collaborations